Skip to main content
    A

    Arcadia Biosciences Inc (RKDA)

    Official site

    CONSUMER DEFENSIVE • PACKAGED FOODS • NASDAQ

    $0.20
    +0.00 (+1.24%)

    Market Cap: $499,910

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(19/38)
    Avg Surprise
    -28.25%
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 13
    		$-0.38N/AN/ABeat+88.3%
    Mar 26
    Reported May 14
    		$-2.11$-0.80-163.16%Miss-210.8%
    Dec 25
    Reported Mar 26
    		$-0.98$-0.09-984.33%Miss+67.4%
    Sep 25
    Reported Nov 7
    		$0.62$-0.54+214.81%Beat+171.3%
    Jun 25
    Reported Aug 14
    		$-3.26$-0.79-312.66%Miss-517.9%
    Mar 25
    Reported May 8
    		$1.90$-0.98+293.88%Beat+206.7%
    Dec 24
    Reported Mar 20
    		$-2.99$-0.89-235.96%Miss-18.7%
    Sep 24
    Reported Nov 12
    		$-0.87$-0.77-12.99%Miss+54.0%
    Jun 24
    Reported Aug 13
    		$0.78$1.55-49.68%Miss+27.9%
    Mar 24
    Reported May 9
    		$-1.78$-2.21+19.46%Beat+83.6%
    Dec 23
    Reported Mar 28
    		$-2.52$-2.58+2.33%Beat+59.9%
    Sep 23
    Reported Nov 9
    		$-1.89$-2.93+35.49%Beat+75.5%
    Jun 23
    Reported Aug 10
    		$0.61N/A+112.40%Beat+107.4%
    Mar 23
    Reported May 11
    		$-10.86$-6.60-64.55%Miss-24.3%
    Dec 22
    Reported Mar 30
    		$-6.29$-6.80+7.50%Beat+43.8%
    Sep 22
    Reported Nov 10
    		$-7.70$-7.60-1.32%Miss+37.7%
    Jun 22
    Reported Aug 11
    		$-8.28$-12.40+33.23%Beat+5.5%
    Mar 22
    Reported May 12
    		$-8.74$-12.40+29.52%Beat+26.3%
    Dec 21
    Reported Mar 30
    		$-11.20$-12.00+6.67%Beat-131.8%
    Sep 21
    Reported Nov 15
    		$-12.35$-9.60-28.65%Miss+51.6%
    Jun 21
    Reported Aug 16
    		$-8.76$-9.20+4.78%Beat+69.3%
    Mar 21
    Reported May 17
    		$-11.86$-12.20+2.79%Beat+54.0%
    Dec 20
    Reported Mar 30
    		$35.20$-16.40+314.63%Beat+276.0%
    Sep 20
    Reported Nov 12
    		$-25.52$-21.60-18.15%Miss+30.9%
    Jun 20
    Reported Aug 13
    		$-28.56$-24.20-18.02%Miss+31.2%
    Mar 20
    Reported May 13
    		$-25.80$-19.20-34.38%Miss+25.2%
    Dec 19
    Reported Mar 25
    		$-20.00$-23.00+13.04%Beat-257.1%
    Sep 19
    Reported Nov 6
    		$-36.93$-31.20-18.37%Miss-11.0%
    Jun 19
    Reported Aug 14
    		$-41.50$-37.60-10.37%Miss+48.6%
    Mar 19
    Reported May 8
    		$-34.48$-40.40+14.65%Beat+82.3%
    Dec 18
    Reported Mar 27
    		$-5.60N/A+81.58%Beat-302.9%
    Sep 18
    Reported Nov 7
    		$-33.26$-45.20+26.42%Beat+51.0%
    Jun 18
    Reported Aug 8
    		$-80.80$-51.60-56.59%Miss-12.2%
    Mar 18
    Reported May 9
    		$-194.40$-56.00-247.14%Miss-143.0%
    Dec 17
    Reported Mar 20
    		$-1.39$-2.00+30.50%Beat+98.7%
    Sep 17
    Reported Nov 9
    		$-67.92$-64.00-6.13%Miss-
    Jun 17
    Reported Aug 10
    		$-72.00$-88.00+18.18%Beat-
    Mar 17
    Reported May 10
    		$-80.00$-56.00-42.86%Miss-
    Dec 16
    Reported Mar 8
    		$-104.00$-80.00-30.00%Miss-

    Key Metrics

    Valuation
    P/E Ratio-0.07EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-234.50%Operating Margin-34.40%
    ROE-430.90%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage-0.09x
    Current Ratio3.49xQuick Ratio2.92x
    Trading Statistics
    Beta0.55Avg Volume5.08M
    52-Week High$5.6352-Week Low$0.16

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.25
    SMA 20$0.30
    SMA 50$0.43
    SMA 200$1.13
    EMA 10$0.25
    EMA 20$0.30
    EMA 50$0.42
    EMA 200$1.21

    MACD

    Line: -0.07Signal: -0.06Hist: -0.00

    ADX

    ADX: 17.7+DI: 14.9-DI: 23.6

    Aroon & PSAR

    Aroon Up36.0
    Aroon Down96.0
    PSAR$0.35

    Bollinger Bands

    Upper Band$0.46
    Lower Band$0.15
    %B Position10360%(Upper)
    Band Width0.18

    RSI (14-Day)

    Oversold
    20.6

    Momentum Oscillators

    Stoch %K22.3
    Stoch %D14.9
    Williams %R-72.1
    ROC (10d)-28.3%
    Momentum-0.08
    CCI (20d)-113.9
    MFI (14d)8.5

    Volatility Measures

    ATR (14d)$0.05(25.7%)
    StdDev (20d)0.08
    Hist Vol106.8%(High)

    Volume Flow

    VWAP$0.20
    OBV107.7M
    AD Line-97.5M
    CMF (20d)0.247

    Volume Metrics

    Avg Vol (20d)5.6M
    Vol Ratio0.1x(Low)
    VWMA (20d)$0.28

    Pivot Points

    R3$0.28
    R2$0.25
    R1$0.22
    Pivot Point$0.19
    S1$0.17
    S2$0.14
    S3$0.11

    Advanced Oscillators

    TSI-50.76
    Ultimate Osc57.4
    KST-429.83

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.44M$1.10M$901,000$1.30M$1.46M$1.20M$1.22M$1.54M$1.31M$987,000$627,000$1.30M
    Cost of Revenue$812,000$700,000$708,000$884,000$824,000$682,000$827,000$1.03M$633,000$471,000$18,000$818,000
    Gross Profit$631,000$400,000$193,000$418,000$631,000$518,000$388,000$505,000$673,000$516,000$609,000$480,000
    Operating Expenses$1.13M$1.18M$1.57M$1.57M$1.13M$-12,000$2.67M$2.27M$-1,307,000$2.10M$-7,000$1.88M
    R&D$0$0$0$0$9,000$0$13,000$24,000$10,000$6,000$-337,000$15,000
    SG&A$1.13M$1.18M$1.57M$1.57M$2.12M$1.74M$2.65M$2.24M$2.68M$2.06M$227,000$1.86M
    Operating Income$-496,000$-779,000$-1,377,000$-1,152,000$-501,000$530,000$-2,280,000$-1,760,000$1.98M$-1,588,000$616,000$-1,397,000
    Interest Income$-5,423,000$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$-2,000$-5,000$2,000$-7,000$-9,000$-207,000$-354,000$-233,000$-150,000$-45,000$-157,000$-133,000
    Income Before Tax$-2,834,000$-2,881,000$-3,305,000$-585,000$31,000$2.60M$-3,862,000$-1,197,000$1.70M$-950,000$1.36M$-639,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-6,266,000$-4,385,000$-1,336,000$856,000$-4,458,000$2.60M$-4,064,000$-1,612,000$1.06M$-2,423,000$-2,853,000$-2,567,000
    EBITDA$2.59M$-2,878,000$-3,301,000$-585,000$50,000$2.44M$-4,112,000$-1,334,000$1.73M$-767,000$7.51M$-505,000
    EBIT$2.59M$-2,886,000$-3,303,000$-592,000$22,000$2.39M$-4,216,000$-1,430,000$1.55M$-995,000$7.28M$-772,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RKDA

    News

    Arcadia Biosciences files S-8 as Nasdaq tests Arcadia Biosciences stock

    Arcadia Biosciences filed an S-8 registration for employee-plan shares on September 30, 2026, while facing a Nasdaq compliance issue due to its stockholders' equity being below the USD 2.50 million minimum. The company...

    ad-hoc-news.de•10/15/26•Somewhat-Bearish

    Which of BIO-key International (NASDAQ:BKYI), Arcadia Biosciences (NASDAQ:RKDA), SU Group Holdings (NASDAQ:SUGP), Nexentis Technologies (NASDAQ:NXTS) or Diginex (NASDAQ:DGNX) Is Declining Before the Bell Despite Quiet Turnover?

    Five stocks, BIO-key International (BKYI), Arcadia Biosciences (RKDA), SU Group Holdings (SUGP), Nexentis Technologies (NXTS), and Diginex (DGNX)...

    kalkine.ca•10/15/26•Somewhat-Bearish

    RKDA Forecast — Price Target — Prediction for 2027

    This article provides an overview of Arcadia Biosciences, Inc. (RKDA) stock performance and financial data, including its current price, historical highs and lows, market capitalization...

    TradingView•10/14/26•Bearish

    A3D7B0 Forecast — Price Target — Prediction for 2027

    This article provides a detailed financial overview of Arcadia Biosciences, Inc. (A3D7B0) stock, including its current price, market capitalization, and historical highs and lows. It also covers recent earnings, revenue...

    TradingView•10/14/26•Bearish

    Arcadia Biosciences stock stays below Nasdaq's USD 1 threshold

    Arcadia Biosciences (RKDA) stock continues to trade below Nasdaq's $1 minimum bid price requirement, closing at $0.29 on October 5, 2026. The company faces a Nasdaq compliance plan deadline of October 15, 2026...

    AD HOC NEWS•10/6/26•Bearish

    RKDA Valuation and Fair Value

    P/E
    -0.1x
    Forward P/E
    36.6x
    PEG
    -0.1x
    P/B
    1.0x
    See GNG's fair value

    RKDA Profitability: Margins, ROIC and FCF

    Gross margin
    34.6%
    Operating margin
    -34.4%
    Net margin
    -234.5%
    ROE
    -430.9%
    FCF margin
    -53.4%

    RKDA Competitors

    CompanyTicker
    Kaival Brands Innovations Group IncKAVL
    22nd Century Group IncXXII
    Steakholder Foods LtdSTKH
    Amaze Holdings IncAMZE
    Visionary Education Technology Holdings Group Inc.GV
    Davis Commodities Limited Ordinary SharesDTCK
    Maison Solutions IncMSS
    CHS Inc CL PrefCHSCL

    Sector: Consumer Defensive

    RKDA Bull Case vs Bear Case

    Bear case

    • RKDA has a -234.5% net profit margin.
    • RKDA beat EPS estimates in 25.0% of its last 8 reported quarters.
    • RKDA's quarterly revenue changed -0.8% year over year.

    RKDA Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -155.3%

    Frequently Asked Questions About RKDA

    Does RKDA pay dividends?

    Arcadia Biosciences Inc (RKDA) does not currently pay a regular dividend.

    What is RKDA's market cap?

    Arcadia Biosciences Inc (RKDA) has a market capitalization of $499,910 with a current stock price of $0.20.

    Related stocks

    Sector: Consumer Defensive

    All stocks starting with R

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In